MPM Oncology Impact Management GP LLC's Net Worth

$468 Million

Estimate Recalculated Feb 23, 2024 05:09PM EST

Who is MPM Oncology Impact Management GP LLC?

MPM Oncology Impact Management GP LLC has an estimated net worth of $468 Million. This is based on reported shares across multiple companies, which include Werewolf Therapeutics, Inc., iTeos Therapeutics, Inc., Spring Bank Pharmaceuticals, Inc., Harpoon Therapeutics, Inc., TCR2 THERAPEUTICS INC., SUNESIS PHARMACEUTICALS INC, Oncorus, Inc., and Cullinan Oncology, Inc..

SEC CIK

MPM Oncology Impact Management GP LLC's CIK is 0001721035

Past Insider Trading and Trends

2020 was MPM Oncology Impact Management GP LLC's most active year for acquiring shares with 24 total transactions. MPM Oncology Impact Management GP LLC's most active month to acquire stocks was the month of June. 2021 was MPM Oncology Impact Management GP LLC's most active year for disposing of shares, totalling 67 transactions. MPM Oncology Impact Management GP LLC's most active month to dispose stocks was the month of March. 2019 saw MPM Oncology Impact Management GP LLC paying a total of $13,506,258.12 for 7,269,851 shares, this is the most they've acquired in one year. In 2021 MPM Oncology Impact Management GP LLC cashed out on 60,306,699 shares for a total of $21,911,769.21, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

iTeos Therapeutics, Inc. (ITOS) Snapshot price: $10.52

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.00%
-200.00
$29.99
-$5,998.00
6M
Scheduled
Apr 9
Form 4
-0.95%
-57.65K
$30.99
-$1,300,850.41
6M
Scheduled
Apr 7 - Apr 8
Form 4
+64.51%
6.06M
$19.00
$6,080,000.00
15.46M
Jul 28
Form 3
0
0
No matching records found

Werewolf Therapeutics, Inc. (HOWL) Snapshot price: $6.22

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1,346.05%
6.21M
$16.00
6.67M
May 4
Form 3
0
0
No matching records found

Harpoon Therapeutics, Inc. (HARP) Snapshot price: $22.4

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.90%
-57.49K
$20.63
-$1,186,189.84
6.33M
Scheduled
May 28 - Jun 2
Form 4
-0.27%
-17.16K
$20.22
-$346,937.78
6.39M
Scheduled
May 26 - May 27
Form 4
-0.25%
-15.91K
$20.18
-$321,030.47
6.4M
Scheduled
May 21 - May 24
Form 4
-0.74%
-47.95K
$20.49
-$982,226.63
6.42M
Scheduled
May 18 - May 20
Form 4
-0.25%
-16.42K
$20.05
-$329,313.92
6.47M
Scheduled
May 13 - May 17
Form 4
-1.04%
-68.26K
$21.04
-$1,436,555.54
6.48M
Scheduled
May 10 - May 12
Form 4
-0.16%
-10.17K
$22.52
-$229,107.07
6.55M
Scheduled
May 5
Form 4
-4.77%
-328.52K
$22.48
-$7,386,435.35
6.56M
Scheduled
Apr 30 - May 4
Form 4
-1.85%
-130.14K
$21.99
-$2,861,368.42
6.89M
Scheduled
Apr 27 - Apr 29
Form 4
-0.13%
-8.97K
$18.97
-$170,229.38
7.02M
Scheduled
Apr 21
Form 4
-0.54%
-38.15K
$19.04
-$726,550.34
7.03M
Scheduled
Apr 16 - Apr 20
Form 4
-0.54%
-38.56K
$20.16
-$777,359.18
7.07M
Scheduled
Apr 13 - Apr 15
Form 4
-0.43%
-30.93K
$21.90
-$677,357.16
7.11M
Scheduled
Apr 9 - Apr 12
Form 4
3.9M
$11.65
-$6,258.00
3.9M
Feb 12
Form 3
0
0
No matching records found

Spring Bank Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found

TCR2 THERAPEUTICS INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
3.37M
$15.00
3.37M
Feb 19
Form 3
0
0
No matching records found